Download Center
You Have Requested The File: PCBL-Phillips-Carbon-Black-Ltd-Initiating-Coverage.pdf
| Subscribe To Our Free Newsletter |
Latest Stock Market News
Latest Articles
- Comment on Prashant Jain has invested in a portfolio of promising small and nano-cap stocks from different sectors. by Anil In reply to <a href="https://rakesh-jhunjhunwala.in/prashant-jain-has-invested-in-a-diversified-portfolio-of-promising-small-and-nano-cap-stocks-from-different-sectors/#comment-14747"> .....
- Comment on Prashant Jain has invested in a portfolio of promising small and nano-cap stocks from different sectors. by Anil This doesn't seem correct. How can we be sure its same Prashant Jain as of P3 Investments. Some of these securities don't match with Prashant Jain style of investments. .....
- Comment on Algo trader has earned profit of Rs 32 crore in 12 months on capital of Rs 30 crore which is a return in excess of 100% by rishabh too good to be true, lets when the the true colours open up, till then stay cautious .....
Latest Stock Research Reports
- TVS Motor: Healthy Volume Growth: Karvy Valuation & Rating: In view of TVSL gaining market shares, better industry outlook and healthy exports, we increase our volume estimates by 8% and 9.5% for FY15 and FY16, accordingly we increa .....
- Buy TVS Motor; target of Rs 175: Sharekhan The TVS management is looking to leverage on a complete scooter portfolio in FY2015. It also expects motorcycle volumes, which were lacklustre in FY2014, to pick up in FY2015 aided especially by th .....
- Dish TV has several catalysts: Goldman Sachs Several catalysts lined up; Favorable risk-reward; Maintain Buy Source of opportunity We retain our Buy on Dish TV as we expect the company to benefi .....
Latest Discussions In The Forum
- Review of 12 Specialty Chemicals stocks Review of 12 Specialty Chemicals stocks (SRF, Navin Fluorine, Gujarat Fluoro, Archean Chem, Clean Sciences, Tatva Chintan, Galaxy Surfactants, Rossari Biotech, EPL, Chemplast Sanmar, Sudarshan Chemica .....
- Senco Gold is quoting at a bargain & is a ‘Gold’en opportunity to buy Senco Gold is quoting at a bargain & is a ‘Gold’en opportunity to buy. Its' return ratios are in line with or better than most organized players. There is a big valuation gap. Unwarranted .....
- Buy PNC Infratech for target price of Rs 460 PNC Infratech is a strong executor in roads & water infra segments. It reported 30.6% revenue CAGR in FY18-23; operating margin of 13-14% & robust return ratios (RoCE: ~20%). Asset monetisatio .....
Latest Research Reports
| September 24th, 2023 |
| Review of 12 Speciality Chemicals stocks with Buy, Hold & Reduce Recommendations by ICICI Securities |
Speciality Chemicals, Chemical prices for Jul’23 |
| September 23rd, 2023 |
| Senco Gold ‘Gold’en opportunity – At a bargain; initiate with BUY: Emkay |
Senco Gold boasts of being one of the top-2 as regards revenue share in the ~Rs800bn eastern market, abetted by strongest brand accessibility vs peers, in terms of product, price & penetration |
| September 23rd, 2023 |
| Buy PNC Infratech for target price of Rs 460. Asset monetisation – a key trigger ahead: ICICI Direct |
PNC Infratech has established itself as a strong executor in roads and water infra segments. Additionally, superior execution capabilities via ownership of modern |
| September 18th, 2023 |
| JB Chem is the preferred pick due to aggressive growth focus & high return ratios: Nirmal Bang |
JB Pharma remains our preferred pick, mainly underpinned by aggressive growth focus in the Domestic+CDMO business, high return ratios, lean B/S and healthy FCF |
| September 16th, 2023 |
| KEC International is on the cusp of a major turnaround driven by stellar growth. Buy for target price of Rs 816: Yes Securities |
The company is on the cusp of a major turnaround driven by stellar growth in its TAM, sequential margin recovery, and reduction of working capital to normalized levels |
| September 16th, 2023 |
| Kilpest is available at a discount of ~51% to the average P/E ratio of two prominent diagnostic players. Buy for 43% upside: Nuvama |
Kilpest India (KLPI) has seen multiple transformations in the last ~50 years of existence. Based in Bhopal, it started with agrochemicals in 1972 and forayed into the niche molecular diagnostics business in FY10 through its subsidiary 3B Black Bio Biotech India |
| September 16th, 2023 |
| Astra Microwave Products is well poised for strong growth ahead. Buy for target price of Rs 510 (27% upside): ICICI Direct |
Astra Microwave Products (AMPL), incorporated in 1991, is engaged in design, development and manufacture of sub-systems for Radio Frequency and microwave systems, primarily used in defence, space & meteorology |
| September 10th, 2023 |
| Five Star Business Finance has huge untapped opportunity of INR 22trn. Buy for target price of Rs 860 (19% upside): ICICI Sec |
Five Star Business Finance’s FY23 annual report provides an insight on how it is progressing towards its vision of “reaching the unreached through suitable credit solution” and capturing the INR 22trn MSME lending opportunity. AUM growth reviving to 37% in FY23 vs 14% CAGR between FY20-22 (covid impact) is a testimony to its agility and business resiliency. In a high human touch model, adherence to standard-operating-process (SOPs) becomes a prerequisite, and negligible frauds / mishandling of cash in FY23 (and even in previous years) reflects its tight control on processes and staff quality. Notably, gross stage 3 increased marginally to 1.36% in FY23 vs 1.06% in FY22 despite the implementation of daily DPD recognition from Oct’22. Maintain BUY with an unchanged target price of INR 860, valuing the stock at 4.5x on Sep’24 BVPS |
| September 9th, 2023 |
| Beta Drugs has delivered a healthy performance. Buy for target price of Rs 1325 (27% upside): Nuvama |
Beta Drugs (BETADR) is one of the leading players in the domestic oncology space and ranks among the top 10 in the cytotoxic market. Equipped with three state-of-the-art manufacturing facilities, it produces and markets a wide range of oncology (anti-cancer) drugs, which are available across major government and private hospitals. It expanded, upgraded, and received regulatory approvalsfrom INVIMA (Colombia)/INVISA (Brazil) for its key facilities which will aid exports |
| September 9th, 2023 |
| Lemon Tree Hotels is best placed to ride the industry upcycle. Buy for TP of Rs 140 (40% upside): PL |
LTHL is coming up with a new hotel in Mumbai near the airport under brand Aurika that is expected to be operational in Oct-23. We believe Aurika, Mumbai is likely to be a key growth driver and crown jewel for LTHL |